121 - Complement and the Kidney: Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy

What are the differences between atypical hemolytic uremic syndrome and C3 glomerulopathy? Learn more about these renal diseases, which can occur when the body fails to properly regulate the activation of the complement system, and promising new complement-targeted therapeutic agents that may provide better patient outcomes.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

Speaker Disclosures:
• Bradley Dixon – Consultant, Alexion Pharmaceuticals; Consultant, Apellis Pharmaceuticals

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will compare atypical hemolytic uremic syndrome and C3 glomerulopathy and their relationship to the complement system.